Literature DB >> 18956147

Role of magnetic resonance imaging in the evaluation of diabetic foot with suspected osteomyelitis.

U Rozzanigo1, A Tagliani, E Vittorini, R Pacchioni, L Renzi Brivio, R Caudana.   

Abstract

PURPOSE: This study evaluated Magnetic Resonance Imaging (MRI) in infected diabetic foot ulcers.
MATERIALS AND METHODS: Sixteen diabetic patients underwent foot MRI between January 2006 and September 2007 for suspected unilateral osteomyelitis. Three of 16 patients showed radiographic changes due to Charcot neuropathic osteoarthropathy. Twelve of 16 patients also underwent MR angiography of the lower limbs for the purpose of planning surgical or endovascular treatment. The musculoskeletal and vascular MRI studies were retrospectively reviewed by three radiologists.
RESULTS: The final diagnosis, based on clinical, imaging, microbiological and histological findings, was osteomyelitis in 13/16 cases. Foot MRI allowed a correct diagnosis in 15/16 patients, with 1 false positive result demonstrated by computed tomography (CT)-guided bone biopsy. MR angiography of the lower limbs was considered nondiagnostic in 5/12 patients in the infrapopliteal region owing to venous contamination.
CONCLUSIONS: MRI has high sensitivity for the detection of osteomyelitis in the diabetic foot but lower specificity related to Charcot neuropathic osteoarthropathy. If diagnostic uncertainty persists, a bone biopsy is indicated. The inflammatory hyperaemia caused by the ulcer deteriorates the diagnostic quality of 40%-50% of MR angiography studies in the infrapopliteal region. In these cases, selective arteriography is appropriate, as it can be performed in the same session as angioplasty.

Entities:  

Mesh:

Year:  2008        PMID: 18956147     DOI: 10.1007/s11547-008-0337-7

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  18 in total

1.  Diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Jack L LeFrock; Daniel P Lew; Jon T Mader; Carl Norden; James S Tan
Journal:  Clin Infect Dis       Date:  2004-09-10       Impact factor: 9.079

2.  Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics.

Authors:  Mazyar E Ahmadi; William B Morrison; John A Carrino; Mark E Schweitzer; Steven M Raikin; Hans P Ledermann
Journal:  Radiology       Date:  2006-02       Impact factor: 11.105

3.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

Authors:  S D Ramsey; K Newton; D Blough; D K McCulloch; N Sandhu; G E Reiber; E H Wagner
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

4.  MRI versus scintigraphy with 99mTc-HMPAO-labelled granulocytes in the diagnosis of bone infection.

Authors:  Enrico Vittorini; Eleonora Del Giudice; Andrea Pizzoli; Roberto Caudana
Journal:  Radiol Med       Date:  2005-04       Impact factor: 3.469

5.  Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation.

Authors:  J G Craig; M B Amin; K Wu; W R Eyler; M T van Holsbeeck; J A Bouffard; K Shirazi
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

6.  Vessel wall calcifications at multi-detector row CT angiography in patients with peripheral arterial disease: effect on clinical utility and clinical predictors.

Authors:  Rody Ouwendijk; Marc C J M Kock; Lukas C van Dijk; Marc R H M van Sambeek; Theo Stijnen; M G Myriam Hunink
Journal:  Radiology       Date:  2006-09-11       Impact factor: 11.105

Review 7.  MR imaging of the diabetic foot: diagnostic challenges.

Authors:  Deep S Chatha; Patricia M Cunningham; Mark E Schweitzer
Journal:  Radiol Clin North Am       Date:  2005-07       Impact factor: 2.303

8.  Osteomyelitis in feet of diabetics: clinical accuracy, surgical utility, and cost-effectiveness of MR imaging.

Authors:  W B Morrison; M E Schweitzer; K L Wapner; P J Hecht; F H Gannon; W R Behm
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

9.  Comparison of multistation MR angiography with integrated parallel acquisition technique versus conventional technique with a dedicated phased-array coil system in peripheral vascular disease.

Authors:  Klaus D Hagspiel; Luke Yao; Ming-Chen Paul Shih; Brian Burkholder; Eric Bissonette; Nancy L Harthun
Journal:  J Vasc Interv Radiol       Date:  2006-02       Impact factor: 3.464

Review 10.  Assessment and management of foot disease in patients with diabetes.

Authors:  G M Caputo; P R Cavanagh; J S Ulbrecht; G W Gibbons; A W Karchmer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

View more
  5 in total

1.  (18)F-FDG PET and PET/CT for the diagnosis of diabetic foot osteomyelitis.

Authors:  N Papanas; A Zissimopoulos; E Maltezos
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

2.  Current challenges in imaging of the diabetic foot.

Authors:  S Eser Sanverdi; Bilge F Ergen; Ali Oznur
Journal:  Diabet Foot Ankle       Date:  2012-10-01

3.  Diabetic foot infections with osteomyelitis: efficacy of combined surgical and medical treatment.

Authors:  Abubakr H Widatalla; Seif Eldin I Mahadi; Mohamed A Shawer; Shadad M Mahmoud; A E Abdelmageed; Mohamed Elmakki Ahmed
Journal:  Diabet Foot Ankle       Date:  2012-10-01

4.  99mTc-besilesomab (Scintimun) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells.

Authors:  Wolf S Richter; Velimir Ivancevic; Johannes Meller; Otto Lang; Dominique Le Guludec; István Szilvazi; Holger Amthauer; Florence Chossat; Amel Dahmane; Carsten Schwenke; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-15       Impact factor: 9.236

5.  Correlating pre-operative MRI measurements of metatarsal Osteomyelitis with surgical clean margins reveals the need for a one centimeter resection margin.

Authors:  Brent Bernstein; Melody Stouder; Eric Bronfenbrenner; Steven Chen; David Anderson
Journal:  J Foot Ankle Res       Date:  2017-08-25       Impact factor: 2.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.